MedPath

METAZYME CAP

METAZYME CAP

Discontinued
DIN Number

00837059

Drug Class

Human

Market Date

Dec 29, 1996

Company
HC

METAGENICS, INC.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00837059
AIG Number0431528001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

AMYLASEActive
Strength: 4400 UNIT / CAP
Monograph: AMYLASE
CELLULASEActive
Strength: 200 UNIT / CAP
Monograph: CELLULASE
LIPOLYTIC ENZYMEActive
Strength: 990 UNIT / CAP
Monograph: LIPOLYTIC ENZYME
PROTEASEActive
Strength: 3600 UNIT / CAP
Monograph: PROTEASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.